CROSE

CROSE
Product Description

Patent-pending dietary supplement developed to support retinal function and macular health in cases of central serous chorioretinopathy, with a targeted formulation designed to sustain the physiological mechanisms involved in cortisol regulation and to protect retinal epithelial and ganglion cells.

D&V farma srls

  • Country/Region:
    Italy
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consumer Goods
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Medical Devices
Nutraceuticals
Out-licensing specialist
Specifications
  • Model
    Hard Capsules
  • Supplied from
    Italy

D&V farma srls

  • Country/Region:
    Italy
  • On CPHI since:
    2023
  • Certificates:
    1
  • Employees:
    1 - 24
Company types
Consumer Goods
Manufacturer/Innovator
OTC
Pharmaceutical company
Primary activities
Medical Devices
Nutraceuticals
Out-licensing specialist

More Products from D&V farma srls (5)

  • CORDEV

    Product CORDEV

    CORDEV has been designed for corneal protection, It has a solid scientific foundation and is supported by clinical and preclinical data that confirm its effectiveness. It is patented, and the trademark is registered in the European Union and the UK. Clinical and preclinical data have been published in...
  • DIAX-D

    Product DIAX-D

    Patent pending dietary supplements desigend for subject affected by diabetic retinopathyIt is able to:Reduce VEGF expressionInhibits vessel formationRestore retinal ability to respond to stimuli

    And It has a neuroprotective function.
  • DIVICOR

    Product DIVICOR

    DIVICOR is a product designed for the treatment of corneal alterations in diabetic patients, It is patented, and the trademark is registered in the European Union and the UK. It has a solid scientific foundation and is supported by clinical and preclinical data demonstrating its effectiveness. Clinica...
  • NATTOLUX

    Product NATTOLUX

    Patent Pending dietary supplement designed for subjects affected by vitreous degeneration. Its ingredients: Reduce inflammationReduce collagen degradationMaintain vitreous clarity
  • SIALIX

    Product SIALIX

    Patent pending dietary supplement designed for subjects affected by glaucoma.It is able to:Reduce VEGF expressionInhibits vessel formationRestore retinal ability to respond to stimuli

    And It has a neuroprotective function.